Cutler Group LP Iveric Bio, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 01, 2023	SELL	$18.67 - $24.56 $57,877 - $76,136	-3,100 Reduced 75.61%	1,000 $1,000
Q4 2022 Feb 07, 2023	SELL	$17.24 - $23.95 $274,116 - $380,805	-15,900 Reduced 79.5%	4,100 $0
Q3 2022 Oct 25, 2022	BUY	$9.4 - $18.59 $188,000 - $371,800	20,000 New	20,000 $10,000
Q3 2021 Oct 26, 2021	BUY	$7.07 - $17.5 $190,890 - $472,500	27,000 New	27,000 $2,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.